生物成分市场规模、份额和成长分析（按产品类型、表达系统和地区）- 产业预测 2025-2032

2023 年全球生物基原料市场规模价值 21.9 亿美元，预计将从 2024 年的 23.9 亿美元成长到 2032 年的 47.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.0%。

全球生物成分市场正经历显着成长，这得益于製药、农业和食品生产等领域对永续和创新解决方案的需求不断增长。生物技术，特别是基因工程和合成生物学的最新进展，导致了生物基成分、酵素和化学物质的激增，它们不仅提供了更高的性能，还提供了环境优势。此外，人们越来越意识到生物基原料在解决资源稀缺和气候变迁等问题的潜力，这也加速了其应用。儘管如此，监管挑战和公众看法将继续在塑造未来市场动态方面发挥关键作用。总体而言，生物基成分的不断发展和接受度将为市场在各行业的进一步扩张和影响力奠定基础。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 专利分析

生物成分市场规模（按类型和复合年增长率） (2025-2032)

• 市场概况
• 创新生物技术 API
• 生物相似药

生物材料市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 单株抗体
• 疫苗
• 荷尔蒙和生长因子
• 细胞激素
• 融合蛋白
• 治疗性酵素
• 血液因素

生物材料市场规模（按表达系统和复合年增长率） (2025-2032)

• 市场概况
• 哺乳动物表达系统
• 微生物表现系统
• 酵母表现系统
• 植物表达系统
• 昆虫表达系统

生物成分市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Novo Nordisk（Denmark）
• BASF（Germany）
• Lonza Group（Switzerland）
• DSM（Netherlands）
• Evonik Industries（Germany）
• WuXi AppTec（China）
• Samsung Biologics（South Korea）
• Biocon（India）
• Dr. Reddy's Laboratories（India）
• Divi's Laboratories（India）
• Laurus Labs（India）
• Concord Biotech（India）
• Amgen（USA）
• Genentech（USA）
• Regeneron Pharmaceuticals（USA）
• Gilead Sciences（USA）
• Celgene（USA）
• Bristol Myers Squibb（USA）
• Sanofi（France）
• GlaxoSmithKline（UK）

结论和建议

Global Biotech Ingredients Market size was valued at USD 2.19 billion in 2023 and is poised to grow from USD 2.39 billion in 2024 to USD 4.76 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The global biotech ingredients market is experiencing significant growth, driven by rising demand for sustainable and innovative solutions across sectors like pharmaceuticals, agriculture, and food production. Recent advancements in biotechnology, particularly genetic engineering and synthetic biology, have led to a surge in bio-based ingredients, enzymes, and chemicals that enhance performance while providing environmental advantages. Moreover, increasing awareness of biotech ingredients' potential to tackle issues such as resource scarcity and climate change is accelerating their adoption. Nonetheless, regulatory challenges and public perception continue to play crucial roles in shaping the market's future dynamics. Overall, the continued evolution and acceptance of biotech ingredients position the market for further expansion and influence in various industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biotech Ingredients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biotech Ingredients Market Segments Analysis

Global Biotech Ingredients Market is segmented by Type, Product, Expression System and region. Based on Type, the market is segmented into Innovative Biotech Apis and Biosimilars. Based on Product, the market is segmented into Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes and Blood Factors. Based on Expression System, the market is segmented into Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems and Insect Expression Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biotech Ingredients Market

The global biotech ingredients market is significantly propelled by the increasing demand for sustainable and plant-based products. As consumer awareness surrounding health and environmental issues rises, there is a notable trend toward the preference for products enriched with natural and eco-friendly components. Biotechnology enables the production of these ingredients through innovative processes that are both efficient and environmentally sustainable, minimizing the dependence on conventional agricultural practices. This alignment with consumer desires for clean labels and transparency is driving the widespread adoption of biotech ingredients in diverse sectors, including food, cosmetics, and pharmaceuticals, further boosting market growth.

Restraints in the Global Biotech Ingredients Market

The global biotech ingredients market faces notable restraints primarily due to regulatory hurdles and public apprehension regarding genetically modified organisms (GMOs). Although biotechnology has made significant strides, lingering concerns about the safety of GMOs, their potential environmental repercussions, and ethical implications contribute to consumer skepticism and increased scrutiny from regulatory authorities. Stringent regulations and mandatory labeling for products incorporating biotech ingredients can hinder the market's expansion. To navigate these challenges effectively, it is essential for industry participants to pursue transparent communication, undertake thorough safety evaluations, and implement educational initiatives aimed at building consumer trust and dispelling misconceptions surrounding biotech ingredients.

Market Trends of the Global Biotech Ingredients Market

The global biotech ingredients market is experiencing robust growth as it adapts to shifting consumer preferences towards sustainability and natural offerings. This trend is predominantly fueled by an increasing demand for biotech-derived ingredients across diverse sectors such as food, cosmetics, and pharmaceuticals. Innovations in genetic engineering and bioprocessing techniques are paving the way for the development of novel ingredients with enhanced functionalities, thereby broadening application scopes. Supportive regulatory frameworks are bolstering biotech innovation, while strategic collaborations between biotech companies and conventional manufacturers are seamlessly integrating these ingredients into mainstream products. The landscape is increasingly characterized by a pronounced pivot towards bio-based solutions that resonate with environmentally aware consumers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Biotech Ingredients Market Size by Type & CAGR (2025-2032)

• Market Overview
• Innovative Biotech Apis
• Biosimilars

Global Biotech Ingredients Market Size by Product & CAGR (2025-2032)

• Market Overview
• Monoclonal Antibodies
• Vaccines
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Blood Factors

Global Biotech Ingredients Market Size by Expression System & CAGR (2025-2032)

• Market Overview
• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems

Global Biotech Ingredients Market Size & CAGR (2025-2032)

• North America (Type, Product, Expression System)
  • US
  • Canada
• Europe (Type, Product, Expression System)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Expression System)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Expression System)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Expression System)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Divi's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laurus Labs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Concord Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations